Michael T. Andriole

Biography

 Michael Andriole joined the company in February 2017 as chief financial officer. Prior to joining Endocyte, Mr. Andriole served as vice president, corporate business development at Eli Lilly and Company with responsibility for international transactions, including in/out licensing, JV formation and M&A. Mr. Andriole has more than 20 years of experience in a range of financial, strategic and corporate development roles, as well as broad finance and strategic transaction experience across multiple therapeutic areas, including strategic transactions in oncology, immunology and neuroscience. Mr. Andriole graduated cum laude from Xavier University’s Williams College of Business. He received his MBA from Indiana University’s Kelly School of Business.

Research Interest

 General Science